MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1

Lin Cheng1, Tao Yang1, Yongqin Kuang1

  • 1Department of Neurosurgery, Chengdu Military General Hospital, Chengdu, Sichuan 610083, P.R. China.

Oncology Letters
|February 13, 2014
PubMed

Insights

MicroRNA-23a promotes neuroblastoma metastasis by downregulating CDH1. Inhibiting miR-23a suppressed cancer cell invasion, suggesting therapeutic potential for neuroblastoma (NB) treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • CDH1 (E-cadherin) inactivation is crucial for tumor metastasis.
  • CDH1 expression is reduced in metastatic neuroblastoma (NB) tissues compared to primary NB tissues.

Purpose of the Study:

  • To investigate the regulatory mechanisms behind CDH1 downregulation in metastatic NB.
  • To explore the role of microRNAs in CDH1 regulation and NB metastasis.

Main Methods:

  • Comparative analysis of CDH1 mRNA and protein levels in primary versus metastatic NB tissues.
  • Quantification of miR-23a expression in NB tissues.
  • In vitro assays to assess the effect of miR-23a inhibition on NB cell migration and invasion.
  • Luciferase reporter assays to confirm CDH1 as a direct target of miR-23a.

Main Results:

  • miR-23a was significantly upregulated in metastatic NB tissues.
  • Inhibition of miR-23a suppressed NB cell migration and invasion.
  • CDH1 was identified as a direct target gene of miR-23a.
  • Blocking miR-23a expression partially restored CDH1 levels in NB cells.

Conclusions:

  • miR-23a promotes NB cell migration and invasion by directly targeting and downregulating CDH1.
  • miR-23a is a key regulator of metastasis in neuroblastoma.
  • Exogenous miR-23a inhibition presents potential therapeutic value for treating NB metastasis.